Correction to: Oncogene https://doi.org/10.1038/s41388-020-01466-x
Following publication of this article, it was noted that the incorrect image for PEGFP-C1-CUEDC2+miR-619-5p-mimic was presented in Fig. 5e. The correct figure, based on the original raw data, is shown below. This correction does not change the results or conclusions of this paper.
The original article has been corrected.
Fig. 5e.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mu, M., Niu, W., Zhang, X. et al. Correction: LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway. Oncogene 40, 5972–5973 (2021). https://doi.org/10.1038/s41388-021-01990-4
Published:
Issue date:
DOI: https://doi.org/10.1038/s41388-021-01990-4
This article is cited by
-
Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential
Metabolic Brain Disease (2024)
-
m6A-Mediated Upregulation of lncRNA CHASERR Promotes the Progression of Glioma by Modulating the miR-6893-3p/TRIM14 Axis
Molecular Neurobiology (2024)
